Initial Public Offering (Details) - USD ($) |
1 Months Ended | 9 Months Ended |
|---|---|---|
Sep. 17, 2021 |
Sep. 30, 2022 |
|
| Initial Public Offering (Details) [Line Items] | ||
| Public warrant, description | Each Unit consisted of one share of Common Stock and one Public Warrant. Each redeemable Public Warrant entitles the holder to purchase one share of Common Stock at a price of $6.25 per share, will be exercisable upon issuance and will expire five years from issuance. | |
| Initial Public Offering [Member] | ||
| Initial Public Offering (Details) [Line Items] | ||
| Number of sold units (in Shares) | 4,800,000 | |
| Price per unit (in Dollars per share) | $ 5 | |
| Number of sold units, value | $ 24,000,000 | |
| Offering costs | 3,445,200 | |
| Underwriting fees and expenses | 2,137,800 | |
| Costs related to the initial public offering | $ 1,307,400 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Description of expense or revenue offset related to the warrants or rights. No definition available.
|
| X | ||||||||||
- Definition Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Costs incurred during the period, such as those relating to general administration and policy maintenance that do not vary with and are not primarily related to the acquisition or renewal of insurance contracts. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Cash received on stock transaction after deduction of issuance costs. No definition available.
|
| X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
| X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
| X | ||||||||||
- Details
|